Adjuvant FEC Versus EP in Breast Cancer (MIG5)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chemotherapy, Adjuvant
Interventions: DRUG: 5-fluorouracil|DRUG: epirubicin|DRUG: cyclophosphamide|DRUG: epirubicin|DRUG: paclitaxel
Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy